- Staat
- AK
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Disorientation
Eye movement disorder
Feeling hot
Hyperhidrosis
Loss of consciousness
Pallor
Posture abnormal
Symptomtext
Approximately 7 minutes after vaccine administration, client was standing and his eyes started to roll and started to fall to his left. Mom of client was able to catch client, before he hit anything on the ground. Client was unconscious for about 1 minute. 911 was called for EMS. When he came to, he was slightly disoriented. Clients color was pale and he was sweaty and complained of being hot. Client began to improve. Clients breathing was stable to the entire time. Client was laying in mothers lap and began to become disoriented again, and started to loose color in his face and sweat again. At this time Epi Autoinjector was given. EMS arrived approximately 2 minutes after Epi given. Clients breathing remained stable.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 13.12.2021
- Impfdatum
- 30.11.2021
- Beginn
- 30.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dizziness
Loss of consciousness
Seizure like phenomena
Symptomtext
Patient felt dizzy, passed out for few seconds and had a seizure likely activity and recovered well in the room, pt is sent to the ER and was discharge home from the ER
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 21.04.2022
- Impfdatum
- 29.03.2022
- Beginn
- 30.03.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Irritability
Pyrexia
Symptomtext
Fever and fussines developed after receiving vaccines Tmax of 101, higher than expected for normal immune response to vaccines No s/s of infection or other illness Continue ibuprofen, may add APAP as needed when ibuprofen wears off prior to 6 hours Push fluids to prevent dehydration F/u tomorrow if not significantly improved
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 1,2
- Geschlecht
- M
- Eingang
- 04.02.2022
- Impfdatum
- 20.01.2022
- Beginn
- 28.01.2022
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Herpes zoster
Rash vesicular
Varicella virus test positive
Symptomtext
full blown varicella rash, +varicella antigen. Saw Grandma 8 days earlier and she had shingles.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash vesicular
- Hospital-Tage
- -
- Labordaten
- +skin culture swab with +antigen varicella zooster
- Aktuelle Erkrankungen
- none but MGM had shingles and saw 8 days after the varicella vaccine given
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- NKDA or other allergies
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 1,0
- Geschlecht
- F
- Eingang
- 17.01.2022
- Impfdatum
- 06.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Contusion
Skin warm
Urticaria
Symptomtext
Patient was seen at our health location where she was given her 12 month vaccines which included varicella. Patient had a slight bruise then 24 hours later the bruise turned into a large welt and patient anded up getting hives in the area where the welt was. welt was warm to the touch.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 22.12.2021
- Impfdatum
- 06.12.2021
- Beginn
- 10.12.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site rash
Pruritus
Skin warm
Tenderness
Symptomtext
Local injection site rash on right arm with mild tenderness, mild pruritus, and warmth to the touch beginning 4 days after vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- None provided
- Allergien
- None provided
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 14.12.2021
- Impfdatum
- 13.12.2021
- Beginn
- 13.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Depressed level of consciousness
Dizziness
Injection site pruritus
Symptomtext
patient reported "itching" feeling at varivax injection site then "light-headedness", then slumped back and was less alert although some response always able to be elicited throughout. lasted 5 to 18 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- -
- Geschlecht
- U
- Eingang
- 17.10.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
No additional AE reported; Consumer received the VARIVAX vaccine intramuscularly; This spontaneous report was received from pharmacist and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, historical drug, drug reactions/allergies and concomitant therapies were not provided. On 28-SEP-2022, the patient started therapy with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U019904, expiration date: 24-JUN-2023, administered intramuscularly (Incorrect route of product administration) for prophylaxis (strength was not provided). No adverse symptoms were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Healthcare business professional is reporting the administration of improperly stored vaccines; No additional AE reported.; This spontaneous report was received from an office manager regarding to an unknown number of patients of unspecified age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported On unknown dates, the patients were vaccinated with improperly stored doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human Albumin (rHA) (M-M-R II) lot #U017524, expiration date reported as 26-FEB-2023 but upon internal review established as 03-JUN-2023 and lot #U006489, expiration date reported as 03-JUN-2023 but upon internal review established as 26-FEB-2023 (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis; and/or varicella virus vaccine live (oka/merck) (VARIVAX) lot #U019904, expiration date: 24-JUN-2023 and lot #U039948, expiration date: 16-DEC-2022 (dosage regimen, anatomical location and route of administration were not provided) administered as prophylaxis (Product storage error). The improperly stored doses underwent a temperature excursion (temperature was not provided) for an unknown time frame. No adverse events were reported. This is a non-valid report due to lack of patient's identifiers. Follow-up information has been received from an office manager on 14-SEP-2022 concerning a 5-year-old female patient. On 30-AUG-2022, the vaccines measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human Albumin (rHA) (M-M-R II) (lot# U017524) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot# U039948) were administered subcutaneously on left deltoid (LD) and right deltoid (RD) respectively. The patient had one previous dose of each vaccine (unknown dates of administration). This case was previously considered non-valid but per follow-up information it was determined to be valid as patient's details were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 13.05.2022
- Impfdatum
- 11.05.2022
- Beginn
- 12.05.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Vaccination site erythema
Symptomtext
Pt received the varicella vaccination on 5/11/22, on 5/12/22 she noticed a large red area at the site of the varicella vaccination. On 5/13/22 a large area of redness had spread down her upper arm. She called the clinic to inquire about treatment and a Virtual visit was scheduled with Dr. at that time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- being treated for a skin rash (separate from this reaction)
- Vorgeschichte
- -
- Andere Medikamente
- Doxycycline Hyclate 100 mg Tab 1 tab po bid 1 tablet orally every 12 hours x 14 days Lotrisone Cream 1%/0.05% apply to affected area bid for 1 week
- Allergien
- Tylenol causes hives
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.05.2022
- Impfdatum
- 15.03.2022
- Beginn
- 15.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
No additional AE information; Office manager responsible for storage and handling of vaccines reported patient administered MMRII and VARIVAX that experienced supported temperature excursion.; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reactions or allergies were not reported. On 15-MAR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 ml/once, lot #u019904, expiration date: 24-JUN-2023, administered for prophylaxis (strength, and route of administration were not provided) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA - recombinant human albumin) (M-M-R II) subcutaneous injection, 0.5 ml/once, lot #t027937, expiration date: 18-AUG-2022, administered for prophylaxis (strength, and route of administration were not provided) after a temperature excursion (Product storage error).The reporter stated that the vaccines underwent 2 temperature excursions, the first one happened on 03-MAR-2022 with a temperature ranges of 14F up to 46F (40.02F) for 18 hours and 15 minutes and the second excursion happened on 08-MAR-2022 with a temperature of 56.21F for 50 minutes. No additional information about an adverse event was reported.; Sender's Comments: US-009507513-2204USA007163:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
Office manager responsible for storage and handling of vaccines reported patient administered MMRII and VARIVAX that experienced supported temperature excursion. See related AE 02151018 and AE 02151019. No additional AE information. No PQC.; Office manager responsible for storage and handling of vaccines reported patient administered MMRII and VARIVAX that experienced supported temperature excursion. See related AE 02151018 and AE 02151019. No additional AE information. No PQC.; This spontaneous report was received from an office manager referring to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant therapies, concurrent conditions and previous drug reactions or allergies were not reported. On 13-APR-2022, the patient was vaccinated with one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rha) (M-M-R II) 0.5 milliliters (mL), once (lot number T027937 has been verified to be valid, expiration date reported and established as 18-AUG-2022 ) and one dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliters (mL), once (lot number U019904 has been verified to be valid, expiration date reported and established as 24-JUN-2023) (routes of administration, anatomical sites of vaccination, and vaccine schemes were not reported). Both vaccines were administered as prophylaxis. It was reported that the vaccines were exposed to supported temperature excursion before being administered. No additional adverse event was reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA007163:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 25.04.2022
- Impfdatum
- 13.04.2022
- Beginn
- 13.04.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE information; Office manager responsible for storage and handling of vaccines reported patient administered MMRII and VARIVAX that experienced supported temperature excursion.; This spontaneous report was received from an office manager referring to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant therapies, concurrent conditions and previous drug reactions or allergies were not reported. On 13-APR-2022, the patient was vaccinated with one dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant human albumin (rha) (M-M-R II) 0.5 milliliters (mL), once (lot number T027937 has been verified to be valid, expiration date reported and established as 18-AUG-2022 ) and one dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) 0.5 milliliters (mL), once (lot number U019904 has been verified to be valid, expiration date reported and established as 24-JUN-2023) (routes of administration, anatomical sites of vaccination, and vaccine schemes were not reported). Both vaccines were administered as prophylaxis. It was reported that the vaccines were exposed to supported temperature excursion before being administered. No additional adverse event was reported (no adverse event). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-2204USA007198: US-009507513-2204USA007134:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.04.2022
- Impfdatum
- 19.01.2022
- Beginn
- 19.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; a patient was administered VARIVAX after a temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, and concurrent conditions were not reported. Concomitant therapies were not reported. On 19-JAN-2022, the patient was vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 0.5 milliliter, lot #U019904, expiration date: 24-JUN-2023, administered for prophylaxis (strength, anatomical location and route of administration were not provided) which was administered after temperature excursion of 12.4 Fahrenheit (?F) during a time frame of 0 hours, 20 minutes and 0 seconds. Previous temperature excursion of 6?F to 14?F (11.6F) for 0 hours 25 minutes and 0 seconds No additional additional adverse events were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.04.2022
- Impfdatum
- 13.01.2022
- Beginn
- 13.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Nurse reporting a patient was administered VARIVAX after a temperature excursion.; This spontaneous report as received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 13-JAN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, lot number U019904, expiration date 24-JUN-2023 (route of administration not reported) for prophylaxis (product storage error). No adverse event was reported. The vaccine underwent a temperature excursion of 12.4 degrees Farhrenheit (?F) for 20 Minutes. Also, the vaccine had undergone a previous temperature excursion from 6?F to 14?F (11.6?F) for 25 Minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.04.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional information provided; Nurse reporting a patient was administered VARIVAX after a temperature excursion.; This spontaneous report as received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 11-JAN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, lot number U019904, expiration date 24-JUN-2023 (route of administration not reported) for prophylaxis (product storage error). No adverse event was reported. The vaccine underwent a temperature excursion of 12.4 degrees Farhrenheit (?F) for 20 Minutes. Also, the vaccine had undergone a previous temperature excursion from 6?F to 14?F (11.6?F) for 25 Minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- U
- Eingang
- 05.04.2022
- Impfdatum
- 11.01.2022
- Beginn
- 11.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
No additional AE reported; Nurse reporting a patient was administered VARIVAX after a temperature excursion. No additional information provided. Additional AE cases: 02138009, 02138049, 02138054, 02138052, 02138050, 02138056, 02138057 field. No additional AE reported. No PQC r; This spontaneous report as received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided. On 11-JAN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) 0.5 milliliter, lot number U019904, expiration date 24-JUN-2023 (route of administration not reported) for prophylaxis (product storage error). No adverse event was reported. The vaccine underwent a temperature excursion of 12.4 degrees Farhrenheit (?F) for 20 Minutes. Also, the vaccine had undergone a previous temperature excursion from 6?F to 14?F (11.6?F) for 25 Minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.04.2022
- Impfdatum
- 07.01.2022
- Beginn
- 07.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Symptomtext
no adverse event; patient was administered VARIVAX after a temperature excursion; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 07-JAN-2022, the patient was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot # U019904 exp date 24-JUN-2023) (route not reported) after a temperature excursion. The temperature of excursion was 12.4?F for a time frame of 20 minutes. The previous temperature excursion was 6?F to 14?F (11.6F) for 25 minutes. This is one of several reports received from the same source.; Sender's Comments: US-009507513-2203USA010794: US-009507513-2203USA010843: US-009507513-2203USA010696: US-009507513-2203USA010654: US-009507513-2203USA010652: US-009507513-2203USA010658: US-009507513-2203USA010686:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 11.03.2022
- Impfdatum
- 09.02.2022
- Beginn
- 11.03.2022
- Tage bis Beginn
- 30,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Pt was given a varivax immunization on 2/9/22 slotted for adult vaccinations. CDC has been contacted and their instruction was the following: there is no indication that a dose of this vaccine even one slotted to an adult age group will have any adverse effect on the patient, CDC informed us that the Pt does not need a re-dose, or follow up care beyond these reports. Pt has not reported any adverse effect.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- Not indicated, per CDC instruction.
- Aktuelle Erkrankungen
- N/A- no adverse reaction occurred, this is to report an error; as this pt was given a vaccine that was slotted for an age group that is 18+ the vaccination dosage does not differ from the peds vaccine dose (Per CDC)
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 13.12.2021
- Impfdatum
- 07.12.2021
- Beginn
- 07.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
no other AE occurred; VARlVAX was administered after a temperature excursion; This spontaneous report has been received from a pharmacist referring to a patient of unknown age and unknown gender. Concomitant medication, pertinent medical history, and drug reactions/allergies were not reported. On 07-DEC-2021, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) 1 dose after a temperature excursion for prophylaxis (lot # U019904, expiration date 24-JUN-2023; strength and route were not reported). Vaccine was stored at 36 F for 46 hours (product storage error). There was no previous temperature excursion. It was confirmed that no other adverse event (AE) occurred.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 10.12.2021
- Impfdatum
- 09.12.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Both MMRV and Varicella were given, medical director was notified and patient was contacted and notified of mistake. No adverse reactions to vaccines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 04.12.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect route of product administration
No adverse event
Symptomtext
No additional AE reported; patient might have received a dose of VARlVAX administered intramuscularly; This spontaneous report as received from a pharmacist refers to a patient of unknown age or gender. Information regarding the patient's drug reactions or allergies, concomitant therapies and pertinent medical history was not provided. On 18-NOV-2021 the patient might have been vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) intramuscularly, 0.5 milliliter, lot # U019904, expiration date 24-JUN-2023, for prophylaxis (formulation, concentration, dose number, frequency, were not reported). The patient was very lean and the angle used to administer varicella virus vaccine live (oka/merck)(VARIVAX) might have reached the patients muscle. No additional adverse event was reported. No product quality complaint (PQC) was involved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect route of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -